-
公开(公告)号:US07132261B2
公开(公告)日:2006-11-07
申请号:US10278481
申请日:2002-10-23
IPC分类号: C12N15/12 , C07K14/705 , C12P21/06
CPC分类号: C07K14/721
摘要: This invention relates to a novel estrogen receptor-related nuclear receptor, hereinafter termed “ERβ” having the amino acid sequence of FIG. 1, 13A or 14A or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1, 13A or 13B or an amino acid sequence functionally similar to that sequence. The invention also relates to DNA sequences encoding the receptor. The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and other hormonal effects.
摘要翻译: 本发明涉及一种新颖的雌激素受体相关的核受体,下文称为“ERbeta”,其具有图1的氨基酸序列。 1,13A或14A或与图1所示的氨基酸序列基本相同的氨基酸序列。 1,3A或13B或与该序列功能相似的氨基酸序列。 本发明还涉及编码该受体的DNA序列。 该受体可用于分离用于治疗诸如前列腺癌,良性前列腺增生症,骨质疏松症或心血管疾病的疾病的分子,以及用于雌激素和其他激素作用的物质的测试。
-
公开(公告)号:US5958710A
公开(公告)日:1999-09-28
申请号:US836620
申请日:1997-05-08
IPC分类号: G01N33/50 , A61K38/00 , A61K45/00 , A61P9/00 , A61P13/08 , A61P19/10 , A61P25/28 , A61P35/00 , C07K14/705 , C07K14/72 , C12N15/09 , C12N15/12 , C12P21/02 , C12Q1/68 , G01N33/15 , G01N33/53
CPC分类号: C07K14/721
摘要: This invention relates to a novel estrogen receptor-related nuclear receptor, hereinafter termed "ER.beta." having the amino acid sequence of FIGS. 1, 13A or 14A or substantially the same ambino acid sequence as the amino acid sequence shown in FIGS. 1, 13A or 13B or an amino acid sequence functionally similar to that sequence. The invention also relates to DNA sequences encoding the receptor. The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and other hormonal effects.
摘要翻译: PCT No.PCT / EP96 / 03933 Sec。 371日期:1997年5月8日 102(e)日期1997年5月8日PCT 1996年9月9日PCT公布。 公开号WO97 / 09348 日期1997年3月13日本发明涉及具有图1和图2的氨基酸序列的新型雌激素受体相关核受体(下文称为“ERβ”)。 1,13A或14A或与图1和图2所示的氨基酸序列基本相同的二氢酸序列。 1,13A或13B或与该序列功能相似的氨基酸序列。 本发明还涉及编码该受体的DNA序列。 该受体可用于分离用于治疗诸如前列腺癌,良性前列腺增生症,骨质疏松症或心血管疾病的疾病的分子,以及用于雌激素和其他激素作用的物质的测试。
-
公开(公告)号:US06525188B2
公开(公告)日:2003-02-25
申请号:US09909325
申请日:2001-07-19
IPC分类号: C12N1512
CPC分类号: C07K14/70567 , A61K38/00
摘要: This invention provides an isolated receptor having the amino acid sequence of FIG. 1 (SEQ ID NO:2) or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1 (SEQ ID NO:2) or an amino acid sequence functionally similar to that sequence, and DNA sequences encoding such a receptor.
摘要翻译: 本发明提供了具有图1的氨基酸序列的分离的受体。 1(SEQ ID NO:2)或与图1所示的氨基酸序列基本相同的氨基酸序列。 1(SEQ ID NO:2)或与该序列功能相似的氨基酸序列,以及编码这种受体的DNA序列。
-
4.
公开(公告)号:US06277976B1
公开(公告)日:2001-08-21
申请号:US08776844
申请日:1997-06-24
IPC分类号: C12N1512
CPC分类号: C07K14/70567 , A61K38/00
摘要: This invention provides an isolated receptor having the amino acid sequence of FIG. 1 (SEQ ID NO:2) or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1 (SEQ ID NO:2) or an amino acid sequence functionally similar to that sequence, and DNA sequences encoding such a receptor.
摘要翻译: 本发明提供了具有图1的氨基酸序列的分离的受体。 1(SEQ ID NO:2)或与图1所示的氨基酸序列基本相同的氨基酸序列。 1(SEQ ID NO:2)或与该序列功能相似的氨基酸序列,以及编码这种受体的DNA序列。
-
公开(公告)号:US06617120B2
公开(公告)日:2003-09-09
申请号:US09909326
申请日:2001-07-19
IPC分类号: C12N1585
CPC分类号: C07K14/70567 , A61K38/00
摘要: This invention provides an isolated receptor having the amino acid sequence of FIG. 1 (SEQ ID NO:2) or substantially the same amino acid sequence as the amino acid sequence shown in FIG. 1 (SEQ ID NO:2) or an amino acid sequence functionally similar to that sequence, and DNA sequences encoding such a receptor.
摘要翻译: 本发明提供了具有图1的氨基酸序列的分离的受体。 1(SEQ ID NO:2)或与图1所示的氨基酸序列基本相同的氨基酸序列。 1(SEQ ID NO:2)或与该序列功能相似的氨基酸序列,以及编码这种受体的DNA序列。
-
公开(公告)号:US20060211671A1
公开(公告)日:2006-09-21
申请号:US11241331
申请日:2005-09-30
申请人: Claes Ohlsson , Jan-Ake Gustafsson , Margaret Warner , Bo Angelin
发明人: Claes Ohlsson , Jan-Ake Gustafsson , Margaret Warner , Bo Angelin
摘要: This invention relates to the field of estrogen receptors and particularly though not exclusively on the effect of estrogen receptors and ligands for estrogen receptors on the prevention or treatment of obesity. The invention also relates to the effect of estrogen receptors and their ligands on lipoprotein levels in mammals.
-
-
-
-
-